Close

Amgen (AMGN) Announces Repatha Phase 3 GLAGOV Trial Met Primary, Secondary Endpoints

Go back to Amgen (AMGN) Announces Repatha Phase 3 GLAGOV Trial Met Primary, Secondary Endpoints